Login to Your Account



Financings Roundup

Aastrom Brings in $40M for Recently Launched CLI Trial

By Staff Reports


Monday, March 12, 2012

Earlier this month, Aastrom Biosciences Inc.'s president and CEO, Tim Mayleben, told BioWorld Today that his firm likely would complete a financing this quarter to help support the recently launched Phase III critical limb ischemia (CLI) trial. (See BioWorld Today, March 2, 2012.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription